|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: Microvascular complications: evaluation and monitoring relevance to clinical practice, clinical trials, and drug development
Adam Greenstein
Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, M13 9NT, UK
Mitra Tavakoli
Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, M13 9NT, UK
Moaz Mojaddidi
Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, M13 9NT, UK
Ahmed Al-Sunni
Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, M13 9NT, UK
Glenn Matfin
Division of Endocrinology and Diabetes, Department of Medicine, New York University School of Medicine, New York, USA
Rayaz A Malik
Division of Cardiovascular and Endocrine Sciences, University of Manchester, Manchester, M13 9NT, UK, Rayaz.a.malik{at}man.ac.uk
The long-term microvascular complications of diabetes pose a major health burden. Although, much of the focus has been on the macrovascular much of the focus has been on the macrovascular complications, it is clear that the microvascular complications have a significant impact on both morbidity and mortality amongst diabetic patients. Indeed retinopathy, nephropathy, and neuropathy compete as the leading causes of premature blindness, end-stage renal disease, and non-traumatic lower-limb amputation, respectively. Furthermore, complications develop and progress in unison and indeed share many common risk factors. Effective evaluation and monitoring of these complications in clinical practice is clearly important, however, it is also relevant to clinical addressing microvascular complications, Novel intervention studies, and drug development programs diagnostic and therapeutic strategies are continually evolving in this area and will be discussed in more detail in this review.
Key Words: diagnosis nephropathy neuropathy retinopathy treatment.
References
- Tapp RJ, Shaw JE, de Courten MP et al. Foot complications in Type 2 diabetes: an Australian population-based study. Diabet Med 2003;20:105-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tapp RJ, Shaw JE, Harper CA et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003;26:1731-7.[Abstract/Free Full Text]
- Tapp RJ, Shaw JE, Zimmet PZ et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Am J Kidney Dis 2004;44:792-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.[Free Full Text]
- Alexander CM, Landsman PB, Teutsch SM, Haffner SM NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003;52:1210-14.[Abstract/Free Full Text]
- Cuspidi C., Meani S., Fusi V. et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004;22:1991-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Leoncini G., Ratto E., Viazzi F. et al. Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients. J Intern Med 2005;257:454-60.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mule G., Nardi E., Cottone S. et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005;257:503-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schillaci G., Pirro M., Vaudo G. et al. Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 2004; 43:1817-22.[Abstract/Free Full Text]
- Boulton AJ, Vinik AL, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.[Free Full Text]
- Boulton AJ, Malik RA, Arezzo JC, Sosenko JM Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86.[Free Full Text]
- Malik RA, Williamson S., Abbott C. et al. Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998;352:1978-81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ramsey SD, Newton K., Blough D. et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22:382-7.[Abstract]
- Ollendorf DA, Kotsanos JG, Wishner WJ et al. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes. Diabetes Care 1998;21:1240-5.[Abstract]
- Miranda-Palma B., Sosenko JM, Bowker JH, Mizel MS, Boulton AJ A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 2005;70:8-12.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mojaddidi M., Quattrini C., Tavakoli M., Malik RA Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy. Curr Diab Rep 2005;5:417-22.[CrossRef][Medline]
[Order article via Infotrieve]
- Malik RA, Veves A., Walker D. et al. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol (Berl) 2001;101:367-74.[Medline]
[Order article via Infotrieve]
- Malik RA, Tesfaye S., Newrick PG et al. Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 2005;48:578-85.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Smith AG, Russell J., Feldman EL et al. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care 2006;29:1294-9.[Abstract/Free Full Text]
- Novella SP, Inzucchi SE, Goldstein JM The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 2001;24:1229-31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sumner CJ, Sheth S., Griffin JW et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60:108-11.[Abstract/Free Full Text]
- Smith AG, Howard JR, Kroll R. et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J Neurol Sci 2005;228:65-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Caselli A., Rich J., Hanane T. et al. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology 2003;60:297-300.[Abstract/Free Full Text]
- Krishnan ST, Rayman G. The LDI flare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004;27:2930-5.[Abstract/Free Full Text]
- McArthur JC, Stocks EA, Hauer P. et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol 1998;55:1513-20.[Abstract/Free Full Text]
- Holland NR, Stocks A., Hauer P. et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology 1997; 48:708-11.[Abstract/Free Full Text]
- Holland NR, Crawford TO, Hauer P. et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Rosenberg ME, Tervo TM, Immonen IJ et al. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 2000;41:2915-21.[Abstract/Free Full Text]
- Oliveira-Soto L., Efron N. Morphology of corneal nerves using confocal microscopy. Cornea 2001;20:374-84.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Patel SV, McLaren JW, Hodge DO, Bourne WM Confocal microscopy in vivo in corneas of long-term contact lens wearers. Invest Ophthalmol Vis Sci 2002;43:995-1003.[Abstract/Free Full Text]
- Tuominen IS, Konttinen YT, Vesaluoma MH et al. Corneal innervation and morphology in primary Sjogren's syndrome. Invest Ophthalmol Vis Sci 2003;44:2545-9.[Abstract/Free Full Text]
- Lockwood A., Hope-Ross M., Chell P. Neurotrophic keratopathy and diabetes mellitus. Eye 2006;20:837-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Hossain P., Sachdev A., Malik RA Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 2005;366:1340-3.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Malik RA, Kallinikos P., Abbott CA et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 2003;46:683-8.[Web of Science][Medline]
[Order article via Infotrieve]
- Kallinikos P., Berhanu M., O'Donnell C., Boulton AJ, Efron N., Malik RA Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci 2004;45:418-22.[Abstract/Free Full Text]
- Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003;26:1553-79.[Abstract/Free Full Text]
- Tesfaye S., Chaturvedi N., Eaton SE et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341-50.[Abstract/Free Full Text]
- Martin CL, Albers J., Herman WH et al. Neuropathy among the diabete control and complications trial cohort 8 years after trial completion. Diabetes Care 2006;29:340-4.[Abstract/Free Full Text]
- Oyibo SO, Prasad YD, Jackson NJ, Jude EB, Boulton AJ The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study. Diabet Med 2002;19:870-3.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sonnett TE, Setter SM, Campbell RK Pregabalin for the treatment of painful neuropathy. Expert Rev Neurother 2006;6:1629-35.[Medline]
[Order article via Infotrieve]
- Smith TR Duloxetine in diabetic neuropathy. Expert Opin Pharmacother 2006;7:215-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Parving HH, Mogensen CE, Thomas MC, Brenner BM, Cooper ME Poor prognosis in proteinuric type 2 diabetic patients with retinopathy: insights from the RENAAL study. Qjm 2005;98:119-26.[Abstract/Free Full Text]
- So WY, Kong AP, Ma RC et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006;29:2046-52.[Abstract/Free Full Text]
- Ravera M., Re M., Vettoretti S. Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy. J Am Soc Nephrol 2006;17:S44-S48.[Abstract/Free Full Text]
- Sengul AM, Altuntas Y., Kurklu A., Aydin L. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract 2006;71:210-19.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Epstein M. Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy. Nat Clin Pract Nephrol 2006;2:310-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sandhu S., Wiebe N., Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006;17:2006-16.[Abstract/Free Full Text]
- Skrivarhaug T., Fosmark DS, Stene LC et al. Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: a 24-year follow-up study. Diabetologia 2006;49:2281-90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 2006;124:1297-306.[Abstract/Free Full Text]
- van Hecke MV, Dekker JM, Stehouwer CD et al. Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005;28:1383-9.[Abstract/Free Full Text]
- Chew EY Screening options for diabetic retinopathy. Curr Opin Ophthalmology 2006;17:519-22.
- Klein R., Moss SE, Sinaiko AR et al. The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study. Ophthalmology 2006;113:2231-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98:786-806.[Web of Science][Medline]
[Order article via Infotrieve]
- Shotliff KP, Duncan G. Diabetic retinopathy: summary of grading and management criteria. Prac Diab Int 2006;23:418-20.[CrossRef]
- Jonas JB, Spandau UH, Kamppeter BA et al. Repeated intravitreal highdosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2006;113:800-04.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jonas JB Intravitreal triamcinolone acetonide for diabetic retinopathy. Dev Ophthalmol 2007;39:96-110.[Medline]
[Order article via Infotrieve]
- Jorge R., Costa RA, Calucci D. et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 2006;26:1006-13.[CrossRef][Medline]
[Order article via Infotrieve]
- Palii SS, Caballero S., Jr., Shapiro G., Grant MB Medical treatment of diabetic retinopathy with somatostatin analogues. Expert Opin Investig Drugs 2007;16:73-82.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Aiello LP, Davis MD, Girach A. et al. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy. Ophthalmology 2006; 113:2221-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 4,
166-171 (2007)
DOI: 10.1177/14746514070070040501

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|